Psoriatic Arthritis (DBCOND0028320)

Identifiers

Synonyms
PsA (Psoriatic Arthritis) / Psoriatic Arthritis (PsA / Arthritis, Psoriatic (PsA) / Psoriatic-arthritis / Psoriatic Arthritis (PsA) / Arthritis, Psoriatic / Psoriatic arthritis / Arthropathic psoriasis, unspecified / Arthropathic psoriasis / Psoriatic arthropathy / Arthropathy psoriatic / Psoriatic arthropathies

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Abatacept
A disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as rheumatoid or psoriatic arthritis, and for the prophylaxis of acute graft-versus-host disease.
Adalimumab
A monoclonal anti-tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
Betamethasone
A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.
Bupivacaine
A local anesthetic used in a wide variety of superficial and invasive procedures.
Certolizumab pegol
A tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis.
Corticotropin
A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
Cortisone acetate
A steroid hormone used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and endocrine disorders associated with inadequate production of steroid hormones.
Etanercept
A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.
Hydrocortisone
A glucocorticoid used to treat corticosteroid-responsive dermatoses, endocrine disorders, immune conditions, and allergic disorders.
Hydrocortisone succinate
A corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Infliximab
A monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and ankylosing spondylitis.
Methylprednisolone
A corticosteroid used to treat inflammation or immune reactions across a variety of organ systems, endocrine conditions, and neoplastic diseases.
Methylprednisolone hemisuccinate
A water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Niflumic acid
A cyclooxygenase-2 inhibitor used to alleviate inflammation, pain, and edema associated with acute and chronic inflammatory conditions, such as rheumatoid arthritis, osteoarthritis, post-operative inflammatory conditions, and physical trauma.
Prednisolone
A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.
Prednisone
A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases.
Risankizumab
An interleukin-23 antagonist used to treat plaque psoriasis, psoriatic arthritis, and Crohn's disease in adults.
Sodium aurothiomalate
A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis.
Tetracosactide
A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
Tofacitinib
A Janus kinase (JAK) inhibitor used to treat rheumatic conditions, such as rheumatoid arthritis and ankylosing spondylitis, and ulcerative colitis.
Triamcinolone
A glucocorticoid used to treat a wide variety of inflammatory conditions of organ systems and tissues.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05988684
Effect of Metformin on Carotid Atherosclerosis for Non-diabetic Patients With PsA (CAMPA Study)No drug interventionstreatment4recruiting
NCT03671148
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)treatment3active_not_recruiting
NCT05421442
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish DatabaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02775656
UCB Cimzia Pregnancy Follow-up StudyNo drug interventionsNot AvailableNot Availableterminated
NCT03419143
Safety and Effectiveness of Abatacept in Psoriatic Arthritis ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT01692912
Psoriatic Arthritis Treat to Target vs. Usual CareNo drug interventionssupportive_careNot Availablewithdrawn
NCT01078402
EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European CountriesNo drug interventionsNot AvailableNot Availablecompleted
NCT04541810
A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03456206
Chronic Inflammatory Disease, Lifestyle and Risk of DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT03173144
Chronic Inflammatory Disease, Lifestyle and Treatment ResponseNo drug interventionsNot AvailableNot Availablecompleted
NCT04089514
A Real-world Study of Imraldi® UseNo drug interventionsNot AvailableNot Availablecompleted
NCT04908202
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic DrugsNo drug interventionstreatment3active_not_recruiting
NCT04553302
Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05598684
SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05862584
Impact of Air Pollution on the Course of Inflammatory RheumatismNo drug interventionsbasic_scienceNot Availableactive_not_recruiting
NCT03248284
Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles TendonsNo drug interventionsNot AvailableNot Availableunknown_status
NCT02376790
Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic ArthritisNo drug interventionstreatment3completed
NCT02232321
Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort StudyNo drug interventionsotherNot Availablecompleted
NCT02019602
A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the PlacentaNo drug interventionsother1completed
NCT01891903
to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into SpanishNo drug interventionsNot AvailableNot Availableunknown_status
NCT01694264
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαNo drug interventionsprevention3terminated
NCT01106079
TIght COntrol of Psoriatic ArthritisNo drug interventionstreatment3completed
NCT01083121
Surveillance of Humira Injection in Korean PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT00451243
Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT06580886
Validation of Handheld Ultrasound Devices in RheumatologyNo drug interventionsNot AvailableNot Availablecompleted
NCT06506916
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasistreatment3not_yet_recruiting
NCT06454188
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritistreatment4not_yet_recruiting
NCT06382051
Modifying PEST for Psoriatic Arthritis ScreeningNo drug interventionsscreeningNot Availablenot_yet_recruiting
NCT06263634
Hand Exercises in Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT06059430
Cohort Project of Patients With Inflammatory RheumatismNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06101706
Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis PatientsNo drug interventionsotherNot Availablerecruiting
NCT06004700
Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of VisitsNo drug interventionssupportive_careNot Availablerecruiting
NCT05925842
Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT05393141
The Effects of Weight Loss on Psoriatic ArthritisNo drug interventionssupportive_careNot Availablecompleted
NCT05291819
Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic ArthritisNo drug interventionstreatmentNot Availablerecruiting
NCT05283096
Survey About Diet in Chronic Inflammatory Rheumatic DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT05115370
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19No drug interventionsNot AvailableNot Availablecompleted
NCT05153148
A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritistreatment2completed
NCT04846959
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved IndicationsNot AvailableNot Availablerecruiting
NCT04709354
Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' NailsNo drug interventionsNot AvailableNot Availablecompleted
NCT04335747
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT04325724
Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective of Patients With Psoriatic ArthritisNo drug interventionspreventionNot Availableunknown_status
NCT04341233
Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT06339957
Rheumatology Diet StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04991116
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisNo drug interventionstreatment3recruiting
NCT04209205
Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritistreatment3completed
NCT04190758
GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, SwedenNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04176978
PsA T2T Statin Trial on Carotid and Coronary AtherosclerosistreatmentNot Availablewithdrawn
NCT04152759
Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjectstreatment1completed
NCT04110522
Psoriatic Arthritis D2P ScreeningNo drug interventionsscreeningNot Availablerecruiting
NCT04115839
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapytreatment3terminated
NCT04018599
Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSbasic_science1completed
NCT03986918
Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip SystemNo drug interventionsNot AvailableNot Availableunknown_status
NCT03953378
CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT03816917
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological ReferralNo drug interventionsNot AvailableNot Availablecompleted
NCT03737045
Psoriatic Arthritis and Psoriasis Treatment Decision AidNo drug interventionsotherNot Availableactive_not_recruiting
NCT03693833
CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.treatment2completed
NCT03598751
Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritistreatment3unknown_status
NCT04839315
COVID-19 Vaccination in Rheumatic Disease PatientsNo drug interventionshealth_services_research0terminated
NCT05616871
An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05086042
Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis; Ultrasonography and Magnetic Resonance Imaging FindingsNo drug interventionsNot AvailableNot Availablecompleted
NCT05128500
Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI ProsthesisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05447741
Quantitative Ultrasound of the Enthesis in Fibromyalgia and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05223049
Neuropathic Pain in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05215561
Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPPNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05332730
A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®treatment1completed
NCT05329896
Ticopa Serum Analysis: an Analysis of Blood Samples From the TICOPA StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05590247
Role of Intermittent Fasting in Psoriasis and Psoriatic ArthritisNo drug interventionstreatmentNot Availablerecruiting
NCT05669833
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patientstreatment3recruiting
NCT04433442
Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04434885
Axial Involvement in Psoriatic Arthritis CohortNo drug interventionsNot AvailableNot Availableunknown_status
NCT04345159
Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04426747
Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory ArthritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03151551
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritistreatment4completed
NCT03101670
A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritistreatment2completed
NCT06299917
WORK-ON Vocational Rehabilitation for People With Inflammatory ArthritisNo drug interventionsotherNot Availablerecruiting
NCT03409211
Patterns After Administration of MCFAs in Psoriasis and Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT03411057
Mindfulness Based Stress Reduction in Rheumatic DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT03402087
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patientstreatment1completed
NCT03370133
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasistreatment3completed
NCT03378336
Psoriatic Arthritis Research Collaborative: Biologic Sub-StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03248518
Lessening the Impact of Fatigue in Inflammatory Rheumatic DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT03104400
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)treatment3active_not_recruiting
NCT03058900
Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic ArthritistreatmentNot Availablecompleted
NCT05427942
Yuflyma® (Adalimumab), Patient Experience After SwitchingNot AvailableNot Availableunknown_status
NCT02854163
Effect of Secukinumab in the Treatment of Psoriatic Arthritisbasic_science2completed
NCT03152396
Pharmacist CVD Intervention for Patients With Inflammatory ArthritisNo drug interventionstreatmentNot Availableunknown_status
NCT02538341
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)prevention2completed
NCT02605642
Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From RemicadeNot AvailableNot Availablecompleted
NCT02319759
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)treatment2completed
NCT02414633
Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])No drug interventionsNot AvailableNot Availablecompleted
NCT02349451
A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)treatment2completed
NCT02267642
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritistreatment2completed
NCT02361385
PBR28 PET and Inflammatory ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT02134613
99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes ActivityNo drug interventionsdiagnostic2unknown_status
NCT02103361
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectNot AvailableNot Availablerecruiting
NCT02052609
A Phase 3 Clinical Study of KHK 4827treatment3completed
NCT01939132
Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritistreatment4unknown_status
NCT01901185
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercepttreatment3completed
NCT01892436
Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritistreatment3completed
NCT01845818
Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in BelgiumNo drug interventionsNot AvailableNot Availablecompleted
NCT01768858
Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeNot AvailableNot Availablecompleted
NCT01752634
Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritistreatment3completed
NCT01680159
A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasistreatment3completed
NCT01212770
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritistreatment3completed
NCT01078558
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )No drug interventionsNot AvailableNot Availablecompleted
NCT00946686
To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditionstreatment1completed
NCT00751387
Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in AustraliaNo drug interventionsNot AvailableNot Availablecompleted
NCT00580632
Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00432406
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritistreatment4completed
NCT00317499
Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasisprevention3completed
NCT00267956
An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritistreatment2completed
NCT00023205
Impact of Literacy Level on Patient Education and Health Among People With ArthritisNo drug interventionsNot Available2completed
NCT04065958
Yoga-mindfulness for Pain Management in Inflammatory ArthritisNo drug interventionstreatmentNot Availablesuspended
NCT01848028
PsoBest - The German Psoriasis RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT06583980
INSELMA - a Randomised Controlled TrialNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT06568029
Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT06370221
The Effect of Psoriatic Arthritis on Female Sexual DysfunctionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06176508
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic ArthritisNo drug interventionstreatment2recruiting
NCT06191042
A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic ArthritisNo drug interventionstreatment1recruiting
NCT05954364
Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT05767814
Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of Biologic Therapies.No drug interventionsNot AvailableNot Availablerecruiting
NCT05652608
Stronger Together Psoriatic Arthritis Wellness StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05631223
Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA)No drug interventionstreatmentNot Availablerecruiting
NCT05637905
Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis PatientsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05301621
Accelerometry in Follow up of Arthritis - a Pilot StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05307809
Cytokine Expression in Psoriasis Patients with and Without Joint InvolvementNo drug interventionsbasic_scienceNot Availablerecruiting
NCT05171270
AsseSSing Impact in pSoriatic TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT05155098
2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial SpondyloarthritisNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05075343
Effect of Custom Foot Orthoses in Patients With Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT05046431
Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritistreatment3completed
NCT05051943
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseNo drug interventionsNot AvailableNot Availablecompleted
NCT04924270
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory DiseasesNo drug interventionstreatment2recruiting
NCT04922840
Improved Cardiovascular Health for Patients With Inflammatory Joint DiseasesNo drug interventionstreatmentNot Availablecompleted
NCT04887597
EBIO - Enthesitis Biopsy StudyNo drug interventionsdiagnostic4unknown_status
NCT04804449
Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid OxygenNo drug interventionsNot AvailableNot Availablecompleted
NCT04718428
Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy ControlsNo drug interventionsNot AvailableNot Availablecompleted
NCT04711902
Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.No drug interventionstreatment3completed
NCT06437392
Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04588623
The MEDIPSA Clinical TrialNo drug interventionssupportive_careNot Availablecompleted
NCT04602091
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)No drug interventionsNot AvailableNot Availablerecruiting
NCT04587362
The Diagnostic Ultrasound Enthesitis Tool (DUET) StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT04540809
The Effect of Psoriatic Arthritis on the Functions of the HandNo drug interventionsNot AvailableNot Availablecompleted
NCT04517669
Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical PracticeNo drug interventionsNot AvailableNot Availablerecruiting
NCT04515732
Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)No drug interventionsdiagnostic4unknown_status
NCT04402554
Survey of Cannabis Use in Patients With Chronic Inflammatory ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT04334031
Deployment o the Multidisciplinary Prospective Cohort ImminentNo drug interventionsotherNot Availablerecruiting
NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNo drug interventionsNot AvailableNot Availablecompleted
NCT04200690
Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory DiseasesNo drug interventionshealth_services_researchNot Availableactive_not_recruiting
NCT04191395
Evolution and Treatments of Chronic Inflammatory Systemic DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04183881
A Phase 4 Clinical Study of BrodalumabNo drug interventionstreatment4completed
NCT04180904
Diet Interventions in Psoriatic ArthritisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04108468
GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA (GOLMEPsA)No drug interventionstreatment3completed
NCT04102449
Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With ApremilastNo drug interventionsdiagnostic4withdrawn
NCT04009499
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisNo drug interventionstreatment3active_not_recruiting
NCT03955861
Ultrasound Enthesitis Response in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT03895203
A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT03835780
The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT03840928
PatientSpot Formerly Known as ArthritisPowerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerNo drug interventionstreatment1recruiting
NCT03797872
Psoriatic Oligoarthritis Intervention With Symptomatic thErapyNo drug interventionstreatment4completed
NCT03783026
A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritistreatment4completed
NCT03768271
APACHE Cohort (A Psoriatic Arthritis CoHort)No drug interventionsNot AvailableNot Availablerecruiting
NCT03736161
Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic ArthritisNo drug interventionstreatment3completed
NCT03739853
Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED TrialNo drug interventionstreatment4recruiting
NCT03675308
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) TherapyNo drug interventionstreatment3active_not_recruiting
NCT03620188
Treatment Goals in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT03623867
PsA Secukinumab XCT Structural Progression StudyNo drug interventionstreatment4completed
NCT04261010
TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) StudyNo drug interventionsbasic_scienceNot Availablecompleted
NCT03626038
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating SystemNo drug interventionstreatmentNot Availablerecruiting
NCT03486613
PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory ArthritisNo drug interventionsotherNot Availablecompleted
NCT03496831
Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological DrugsNot AvailableNot Availablecompleted
NCT04632927
Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatmenttreatment3active_not_recruiting
NCT05623345
Psoriatic Arthritis Study of IzokibepNo drug interventionstreatment2 / 3active_not_recruiting
NCT05621369
Psorcast Mobile StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05086029
Carpal Tunnel Syndrome in Patients With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05082805
Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT05458531
Monitoring of Inflammatory ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT05190484
bIosimilar of aDalimumab, an European evAluationNo drug interventionsNot AvailableNot Availableunknown_status
NCT05225623
Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid ObesityNo drug interventionstreatment1completed
NCT06347237
PsA Digital Phenotyping and Inflammation Drivers StudyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05677542
Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05855967
A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years with Moderate-to-Severe Plaque or Active Psoriatic Arthritis in IndiaNo drug interventionstreatment4active_not_recruiting
NCT05858528
HIPPOCRATES Prospective Observational StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05686876
FAPI-PET/CT in Psoriatic ArthritisNo drug interventionsscreening0recruiting
NCT05908240
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic ArthritisNo drug interventionsotherNot Availablerecruiting
NCT05866614
A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and PsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04304326
Comparison of the Effectiveness of Functional Training Versus Resistance Exercises in Patients With Psoriatic ArthritisNo drug interventionssupportive_careNot Availablecompleted
NCT04347798
IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORTNo drug interventionsNot AvailableNot Availablecompleted
NCT04428502
Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)No drug interventionsNot AvailableNot Availablecompleted
NCT04417114
SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasENo drug interventionsprevention4withdrawn
NCT03148860
Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsAtreatment3completed
NCT03470688
Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF AgentsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03454932
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic DiseasesNo drug interventionsNot AvailableNot Availableterminated
NCT03119805
Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.No drug interventionsNot AvailableNot Availablecompleted
NCT03419650
Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)No drug interventionstreatment4completed
NCT03410992
A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisNo drug interventionstreatment3completed
NCT03347110
A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic ArthritisNo drug interventionstreatment2completed
NCT03336281
A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting UstekinumabNo drug interventionsNot AvailableNot Availablecompleted
NCT03074656
The Norwegian Drug Monitoring StudyNo drug interventionstreatmentNot Availablecompleted
NCT03223012
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health ServiceNo drug interventionsNot AvailableNot Availablecompleted
NCT04582084
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT02745080
Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritistreatment3completed
NCT02750800
Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)No drug interventionsNot AvailableNot Availablecompleted
NCT02771210
Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon SiteNo drug interventionstreatment3completed
NCT02775500
Apremilast Pregnancy Exposure RegistryNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02814175
A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)No drug interventionstreatment4completed
NCT02922192
Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive AnalysisNo drug interventionsNot AvailableNot Availablecompleted
NCT02925338
National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real LifeNo drug interventionsNot AvailableNot Availablecompleted
NCT02798211
Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to PlaceboNo drug interventionstreatment4completed
NCT03011242
DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsANo drug interventionsNot AvailableNot Availablecompleted
NCT02986373
A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)treatment2completed
NCT02584855
A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT02572700
Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT02662985
Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)No drug interventionstreatment3completed
NCT02530268
The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) RegistryNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02558361
Treatment With Apremilast in Patients With Psoriatic ArthritisNo drug interventionstreatment4withdrawn
NCT02429895
A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197No drug interventionstreatment2terminated
NCT02475304
Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic ArthritisNo drug interventionstreatment2withdrawn
NCT02470481
A Study in Participants With Psoriatic Arthritis Attending Dermatology ClinicsNo drug interventionsNot AvailableNot Availablecompleted
NCT02486302
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.No drug interventionsNot AvailableNot Availablecompleted
NCT02404350
Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT02413749
DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsANo drug interventionsNot AvailableNot Availablecompleted
NCT02349295
A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT02188654
Metformin in Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT02164214
Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?No drug interventionstreatment3completed
NCT02148640
The NOR-SWITCH StudyNo drug interventionstreatment4completed
NCT02065713
Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis PatientsNo drug interventionstreatment3completed
NCT02029495
Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic ArthritisNo drug interventionstreatment3terminated
NCT02028169
To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)No drug interventionsNot AvailableNot Availablecompleted
NCT01989468
24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT01988103
Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type PsoriasisNo drug interventionstreatment2completed
NCT01965132
Korean College of Rheumatology Biologics and Targeted Therapy RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01925768
Safety and Efficacy Study of Apremilast to Treat Psoriatic ArthritisNo drug interventionstreatment3completed
NCT01871649
Initial Treatment With Golimumab in Early PsANo drug interventionstreatment3completed
NCT01852851
Employment and Arthritis: Making it WorkNo drug interventionssupportive_careNot Availableunknown_status
NCT01818804
The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic ArthritisNo drug interventionspreventionNot Availablecompleted
NCT01690299
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisNo drug interventionstreatment3completed
NCT01692457
A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisNot AvailableNot Availablewithdrawn
NCT01654198
PET/CT in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT01516957
AMG 827 in Subjects With Psoriatic Arthritistreatment2terminated
NCT01474876
Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT01465438
HUmira in Psoriatic ArthritisNo drug interventionstreatment4completed
NCT01392326
Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)treatment3completed
NCT01307423
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)No drug interventionstreatment3completed
NCT01282372
Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With AdalimumabNo drug interventionsNot AvailableNot Availablecompleted
NCT01212757
PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritistreatment3completed
NCT01198509
Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)No drug interventionsNot AvailableNot Availablecompleted
NCT01172938
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT01147874
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology PracticeNo drug interventionsdiagnostic4completed
NCT01123265
National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker StudyNot AvailableNot Availablecompleted
NCT01111240
Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical PracticeNo drug interventionsNot AvailableNot Availablecompleted
NCT01083693
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic DrugsNo drug interventionsNot AvailableNot Availablecompleted
NCT01060098
T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF BlockadeNo drug interventionsNot AvailableNot Availablecompleted
NCT00902005
Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00809614
Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisNo drug interventionstreatment2completed
NCT00659412
A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic ArthritisNo drug interventionstreatment2completed
NCT00509678
Rituxan With or Without Methotrexate in Psoriatic ArthritisNo drug interventionstreatment1completed
NCT00462072
Centocor Microarray Study of PatientsNo drug interventionstreatment4completed
NCT00456092
Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic ArthritisNo drug interventionstreatment2completed
NCT00235885
Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)No drug interventionstreatment3completed
NCT00133315
TNFalfa Blocking Treatment of SpondylarthropathiesNo drug interventionstreatment4completed
NCT00127842
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)No drug interventionstreatment4completed
NCT00051662
Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritistreatment1completed
NCT04269993
Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic ArthritisNo drug interventionsbasic_science2terminated
NCT04277832
Evaluating of New Screening Tool for Arthritis* in PsoriasisNo drug interventionsNot AvailableNot Availablecompleted
NCT04062695
Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvementNo drug interventionstreatment2unknown_status
NCT00001420
Study of Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT06555562
Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory ArthritisNo drug interventionsbasic_scienceNot Availablerecruiting
NCT06544343
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive TherapyNo drug interventionstreatmentNot Availablerecruiting
NCT06402396
Assessing Pain by the painDETECT Questionnaire (PDQ)No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06176586
Mat Pilates Exercise Program in Patients With Axial Psoriatic ArthritisNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT06172426
Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT06144567
Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05772325
The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint DiseaseNo drug interventionspreventionNot Availablerecruiting
NCT05771389
RAFTLIN-1 Levels in Axial Spondyloarthritis and Psoriatic ArthritisNo drug interventionsdiagnosticNot Availablecompleted
NCT05715463
Rheumatology-based Adaptive Intervention for Social Determinants and Health EquityNo drug interventionsotherNot Availablerecruiting
NCT05511519
Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic ArthritisNo drug interventionstreatment2terminated
NCT05080218
COVID-19 VaccinE Response in Rheumatology PatientsNo drug interventionsprevention4recruiting
NCT05055934
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic ArthritisNo drug interventionstreatment2unknown_status
NCT05039216
Biobank for Inflammatory Chronic Diseases and OsteoporosisNo drug interventionsNot AvailableNot Availablerecruiting
NCT04967950
An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis PatientsNo drug interventionstreatment1unknown_status
NCT04908189
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor TreatmentNo drug interventionstreatment3active_not_recruiting
NCT04844008
Do Nanobubbles Improve Joint Hypoxia?No drug interventionsbasic_scienceNot Availablewithdrawn
NCT04800289
Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/DermatologistNo drug interventionsNot AvailableNot Availablerecruiting
NCT04798625
Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive MedicationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04758117
A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05413044
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) RegisterNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04713072
A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic ArthritisNo drug interventionstreatment2completed
NCT04673825
Monitoring Spondyloarthritis With SpA-NetNo drug interventionshealth_services_researchNot Availablecompleted
NCT04655612
Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT06277635
Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic DiseasesNo drug interventionstreatmentNot Availablerecruiting
NCT04610476
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisNo drug interventionstreatment3recruiting
NCT04402086
Rheumatology Patient Registry and BiorepositoryNo drug interventionsNot AvailableNot Availablerecruiting
NCT04321291
Information and Acceptability of BiosimilarsNo drug interventionsotherNot Availablerecruiting
NCT04190108
Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis.No drug interventionsNot AvailableNot Availablecompleted
NCT04163016
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)No drug interventionsbasic_science1completed
NCT04136314
Impact of Decision-Framing in PsoriasisNo drug interventionshealth_services_researchNot Availablecompleted
NCT04115748
Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD TherapyNo drug interventionstreatment3terminated
NCT04109976
A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT03926195
Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisNo drug interventionstreatment2completed
NCT03963401
A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic ArthritisNo drug interventionstreatment2completed
NCT03932110
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin LevelsNo drug interventionsdiagnosticNot Availablecompleted
NCT03896581
A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT03823924
Changes in Body Composition Under Ustekinumab in PsANo drug interventionsNot AvailableNot Availableterminated
NCT03780504
Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in GreeceNo drug interventionsNot AvailableNot Availableunknown_status
NCT03486457
Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT03552276
Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.No drug interventionstreatment2 / 3completed
NCT03533569
Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for ArthritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03531073
Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03214263
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT04755127
Arthroscopic Synovectomy of the Wrist in Inflammatory ArthritisNo drug interventionstreatmentNot Availablerecruiting
NCT04645420
Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis PatientsNo drug interventionsbasic_scienceNot Availablecompleted
NCT04857476
Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound?No drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT04957550
To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic ArthritisNo drug interventionstreatment3enrolling_by_invitation
NCT05257174
The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory ArthritisNo drug interventionstreatmentNot Availableenrolling_by_invitation
NCT05135312
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive ImagingNo drug interventionstreatment4unknown_status
NCT05195814
A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05223062
Medication Adherence in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05683769
microRNA in Erosive Hand Osteoarthritis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05913817
The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.No drug interventionsNot AvailableNot Availablerecruiting
NCT04429776
Tapering of Biologics in Inflammatory Arthritis Patients in RemissionNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03455166
Identification of New Prognostic Markers in Psoriatic ArthritisNo drug interventionsotherNot Availablecompleted
NCT03399708
Immune Metabolic Associations in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT05424926
Sub-cutaneous Infliximab in Inflammatory Rheumatic DiseaseNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03374527
Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous PsoriasisNo drug interventionsNot AvailableNot Availablecompleted
NCT03320876
An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.No drug interventionstreatment2terminated
NCT06125444
Impact of Hyperuricemia on Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT03104374
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)No drug interventionstreatment3active_not_recruiting
NCT05715125
VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)No drug interventionstreatment2terminated
NCT02813720
Distal Erosions and Nail PsoriasisNo drug interventionsNot AvailableNot Availableunknown_status
NCT02841176
Thermography in Assessing Treatment Response to Golimumab in Psoriatic ArthritisNo drug interventionsotherNot Availableterminated
NCT02917434
Effects of Weight-loss Treatment in Obese Patients With Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT02995460
Interval Training Study in Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT02984020
Korean Post-marketing Surveillance for XeljanzNo drug interventionsNot AvailableNot Availablecompleted
NCT02988674
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian FederationNo drug interventionsNot AvailableNot Availablecompleted
NCT02969525
A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory ArthritisNo drug interventionstreatment2completed
NCT02627768
A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT02556034
Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.No drug interventionsNot AvailableNot Availablecompleted
NCT02450396
Pregnancy and Medically Assisted Conception in Rare DiseasesNo drug interventionsNot AvailableNot Availablerecruiting
NCT02483234
Psoriasis-Arthritis & Bone ProgramNo drug interventionstreatment2completed
NCT02598739
Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic ArthritisNo drug interventionssupportive_careNot Availablecompleted
NCT02472717
Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy StudyNo drug interventionstreatment2withdrawn
NCT02188641
Effect of Exercise and Diet on Psoriatic ArthritisNo drug interventionstreatmentNot Availablecompleted
NCT02154425
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating MothersNo drug interventionsother1completed
NCT02141763
Multiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisNo drug interventionstreatment1completed
NCT02132234
Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisNo drug interventionstreatment4unknown_status
NCT02024646
Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic ArthritisNo drug interventionstreatment3completed
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT01882439
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF InhibitorsNo drug interventionstreatment3completed
NCT01877668
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator StudyNo drug interventionstreatment3completed
NCT01860976
Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT01833468
Functional Limitations Due To The Foot Involvement In SpondyloarthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT01797224
OTIS Autoimmune Diseases in Pregnancy ProjectNo drug interventionsNot AvailableNot Availablerecruiting
NCT01559038
Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT01316224
Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT01273519
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With AdalimumabNo drug interventionsNot AvailableNot Availablecompleted
NCT01163916
Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical CareNo drug interventionsNot AvailableNot Availablecompleted
NCT01139918
Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT01169844
Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisNo drug interventionstreatment2completed
NCT01078610
Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical RoutineNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00963313
A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00884468
Study Evaluating Anxiety and Depression in Patients With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00643526
A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorNo drug interventionstreatment0completed
NCT00534313
Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic ArthritisNo drug interventionstreatment2terminated
NCT00517101
Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With SpondyloarthropathyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00427362
A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)No drug interventionstreatment3completed
NCT00245960
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic ArthritisNo drug interventionstreatment4completed
NCT00195689
Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT05631457
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)treatment3not_yet_recruiting
NCT02538757
Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE)prevention2active_not_recruiting
NCT06259890
Influence of Sodium Intake in spondyLoarthriTesNo drug interventionsbasic_scienceNot Availablerecruiting
NCT03008590
Low Dose Naltrexone for Chronic Pain From ArthritisNo drug interventionstreatment2completed
NCT05071664
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisNo drug interventionstreatment2active_not_recruiting
NCT01976364
Open-Label Extension Study Of Tofacitinib In Psoriatic ArthritisNo drug interventionstreatment3completed
NCT02912221
Stepping Up For Inflammatory ArthritisNo drug interventionssupportive_careNot Availablecompleted
NCT03106051
Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT05657847
Novel Complex Radiodiagnostics of Peripherial ArthropathiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT03828045
A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological TreatmentNot AvailableNot Availablecompleted
NCT03942783
WORKWELL: Testing Work Advice for People With ArthritisNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00741793
Biologic Treatment Registry Across CanadaNo drug interventionsNot AvailableNot Availablecompleted
NCT05883371
IMPACT - AndHealth Autoimmune Research RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT05083078
A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritisbasic_science1terminated
NCT01087788
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritistreatment3completed
NCT00938015
Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic ArthritisNo drug interventionsNot AvailableNot Availablecompleted
NCT00787137
Single Dose PG102 in Patients With Active Psoriatic ArthritisNo drug interventionstreatment1terminated
NCT00367237
Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)treatment3completed
NCT03565042
Mechanism of Action of Ustekinumab in Psoriatic ArthritisNo drug interventionsNot AvailableNot Availableunknown_status
NCT03662919
One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyNot AvailableNot Availablecompleted
NCT03703934
Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy ControlsNo drug interventionsNot AvailableNot Availablesuspended
NCT00265096
A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritistreatment3completed
NCT00725296
Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)Not AvailableNot Availablecompleted
NCT03452735
Fertility Study of Women With Chronic Inflammatory RheumatismNo drug interventionsNot AvailableNot Availableunknown_status
NCT03747939
Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.treatment4completed
NCT00293722
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by RheumatologistsNot AvailableNot Availablecompleted
NCT00001422
A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritistreatment2completed
NCT03733925
A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritistreatment4completed
NCT03608657
Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)Not AvailableNot Availablecompleted
NCT00239720
PsA Treatment With hOKT3γ1 (Ala-Ala)treatment2terminated
NCT04731831
Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.No drug interventionsNot AvailableNot Availablerecruiting
NCT02294227
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritistreatment3completed
NCT04680676
A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic ArthritisNo drug interventionstreatment2withdrawn
NCT02402894
Follow-up of Person-centered Care of Young Adults With Rheumatic DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00001291
Genetic and Immune Studies of Rheumatoid Arthritis and Related ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT01077362
A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agentstreatment3completed
NCT00998829
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque PsoriasisNo drug interventionsNot AvailableNot Availablecompleted
NCT00090129
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasistreatment3terminated
NCT02886689
C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in FranceNo drug interventionsNot AvailableNot Availablecompleted
NCT05092269
A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsNo drug interventionsother3recruiting
NCT00760669
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT04929210
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseNo drug interventionstreatment4recruiting
NCT01490450
Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) TherapyNo drug interventionstreatment2completed
NCT04936308
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha AgentNo drug interventionstreatment3active_not_recruiting
NCT03142503
The DIET Trial - Dietetic Intervention in Psoriatic ArthritisNo drug interventionspreventionNot Availablecompleted
NCT06077890
Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand ArthritisNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT03096990
A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in BelgiumNo drug interventionsNot AvailableNot Availablecompleted
NCT02875184
A Study of Apremilast Use and Effectiveness in Patients With Psoriatic Arthritis in The NetherlandsNo drug interventionsNot AvailableNot Availablecompleted
NCT00683384
Study Evaluating the Safety of Enbrel (Etanercept)No drug interventionsNot AvailableNot Availablecompleted
NCT00195377
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in SpainNo drug interventionsNot AvailableNot Availablecompleted
NCT05640245
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisNo drug interventionstreatment2completed
NCT04882098
A Study of Guselkumab in Participants With Active Psoriatic ArthritisNo drug interventionstreatment3recruiting
NCT00727298
Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)No drug interventionsNot AvailableNot Availablecompleted
NCT05049798
A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical PracticeNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02719171
BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic ArthritisNo drug interventionstreatment2completed
NCT01199809
A Study of RO5310074 in Patients With Psoriatic ArthritisNo drug interventionstreatment1completed
NCT00293709
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by DermatologistsNo drug interventionsNot AvailableNot Availablecompleted
NCT02436785
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?No drug interventionstreatmentNot Availablecompleted
NCT03158285
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT04821206
PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak InhibitorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01081717
Golimumab Safety and Surveillance Program Using the Ingenix NHI DatabaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00126724
Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis SubjectsNo drug interventionstreatment1 / 2completed
NCT03162796
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)No drug interventionstreatment3completed
NCT05571696
Mind Matters: a High Touch, Low Cost Approach to Improving Mental Health Outcomes in Patients with Psoriatic DiseasesNo drug interventionsotherNot Availablerecruiting
NCT00273858
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic ArthritisNo drug interventionsNot AvailableNot Availableterminated
NCT01313858
A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)No drug interventionsNot AvailableNot Availablecompleted
NCT03796858
A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) TherapyNo drug interventionstreatment3completed
NCT06522035
Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic ArthritisNo drug interventionstreatment1not_yet_recruiting
NCT05000086
A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic ArthritisNo drug interventionstreatment4completed
NCT01009086
A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic ArthritisNo drug interventionstreatment3completed
NCT04173039
Anti-Carbamylated Protein Antibodies in Psoriatic ArthritisNo drug interventionsdiagnosticNot Availablecompleted
NCT02714322
MYL-1401A Efficacy and Safety Comparability Study to Humira®No drug interventionstreatment3completed
NCT04115020
Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory ArthritisNo drug interventionstreatment2withdrawn
NCT02181673
A Study of Golimumab in Participants With Active Psoriatic ArthritisNo drug interventionstreatment3completed
NCT02098694
Physiotherapy-led Outpatient Clinic for Patients With SpondyloarthritisNo drug interventionstreatmentNot Availablecompleted
NCT03625089
Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With ArthritisNo drug interventionspreventionNot Availablewithdrawn
NCT03330769
Ultrasound in Psoriatic Arthritis TreatmentNo drug interventionsNot AvailableNot Availableunknown_status
NCT00161655
Study Evaluating Etanercept and Methotrexate in Plaque PsoriasisNo drug interventionstreatment4completed
NCT00051623
A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic ArthritisNo drug interventionstreatment3completed